Total Payments
$70,941
2024 Payments
$3,729
Companies
44
Transactions
1,146
Medicare Patients
6,433
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$34,944 (49.3%)
Food & Beverage$23,748 (33.5%)
Consulting$6,755 (9.5%)
Travel$5,240 (7.4%)
Education$254.43 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,944 | 15 | 49.3% |
| Food and Beverage | $23,748 | 1,104 | 33.5% |
| Consulting Fee | $6,755 | 6 | 9.5% |
| Travel and Lodging | $5,240 | 16 | 7.4% |
| Education | $254.43 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $51,925 | 322 | $0 (2020) |
| Abbott Laboratories | $6,031 | 191 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,753 | 97 | $0 (2024) |
| ABBVIE INC. | $1,482 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,470 | 79 | $0 (2024) |
| US WorldMeds, LLC | $770.60 | 63 | $0 (2020) |
| Lundbeck LLC | $744.40 | 38 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $730.75 | 35 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $667.91 | 36 | $0 (2023) |
| GE HealthCare | $535.35 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,729 | 76 | Abbott Laboratories ($2,500) |
| 2023 | $3,985 | 112 | Abbott Laboratories ($1,538) |
| 2022 | $2,157 | 122 | Abbott Laboratories ($912.42) |
| 2021 | $2,102 | 127 | Abbott Laboratories ($304.48) |
| 2020 | $2,774 | 139 | Medtronic USA, Inc. ($951.30) |
| 2019 | $14,741 | 194 | Medtronic USA, Inc. ($12,988) |
| 2018 | $32,346 | 224 | Medtronic USA, Inc. ($30,482) |
| 2017 | $9,108 | 152 | Medtronic USA, Inc. ($7,504) |
All Payment Transactions
1,146 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: Neuromodulation | ||||||
| 12/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Neuromodulation | ||||||
| 12/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/25/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: Musculoskeletal | ||||||
| 11/20/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Neurology | ||||||
| 11/11/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: AMANTADINE | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Central Nervous System | ||||||
| 10/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/15/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Central Nervous System | ||||||
| 10/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Neurology | ||||||
| 09/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $141.09 | General |
| Category: Neuromodulation | ||||||
| 09/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/14/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Neuromodulation | ||||||
| 09/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Central Nervous System | ||||||
| 09/05/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Neurology | ||||||
| 08/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.04 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Adenosine A2A Receptors | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Central Nervous System | ||||||
| 08/21/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $120.13 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,238 | 13,125 | $1.4M | $483,677 |
| 2022 | 24 | 1,494 | 16,780 | $1.7M | $593,886 |
| 2021 | 23 | 1,570 | 18,224 | $1.9M | $649,914 |
| 2020 | 27 | 2,131 | 14,671 | $1.8M | $643,407 |
Total Patients
6,433
Total Services
62,800
Medicare Billing
$2.4M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 300 | 1,360 | $555,857 | $189,878 | 34.2% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 74 | 2,538 | $249,021 | $88,348 | 35.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 248 | 2,907 | $210,972 | $74,159 | 35.2% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2023 | 40 | 5,126 | $100,851 | $34,159 | 33.9% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 97 | 100 | $62,098 | $21,061 | 33.9% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 74 | 411 | $46,523 | $16,332 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 125 | $36,944 | $12,787 | 34.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 23 | 61 | $19,159 | $9,848 | 51.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 33 | 76 | $23,555 | $7,529 | 32.0% |
| 96112 | Administration of developmental test, first hour | Office | 2023 | 53 | 58 | $16,541 | $5,804 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $12,431 | $4,070 | 32.7% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 14 | 29 | $11,755 | $3,489 | 29.7% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 20 | 42 | $8,847 | $3,140 | 35.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 26 | 47 | $8,612 | $3,056 | 35.5% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 14 | 29 | $8,633 | $2,661 | 30.8% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 19 | 37 | $12,759 | $2,161 | 16.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,295 | $1,523 | 35.5% |
| 95961 | Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | Facility | 2023 | 11 | 11 | $3,931 | $1,394 | 35.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 22 | 23 | $2,090 | $741.52 | 35.5% |
| P9041 | Infusion, albumin (human), 5%, 50 ml | Office | 2023 | 40 | 87 | $2,065 | $723.96 | 35.1% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Facility | 2023 | 11 | 11 | $1,245 | $432.41 | 34.7% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Facility | 2023 | 11 | 11 | $1,079 | $379.83 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 318 | 1,749 | $725,478 | $244,484 | 33.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 275 | 3,587 | $266,641 | $93,159 | 34.9% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2022 | 79 | 2,266 | $228,113 | $80,518 | 35.3% |
About Dr. Robert Izor, MD
Dr. Robert Izor, MD is a Neurology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164409108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Izor, MD has received a total of $70,941 in payments from pharmaceutical and medical device companies, with $3,729 received in 2024. These payments were reported across 1,146 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,944).
As a Medicare-enrolled provider, Izor has provided services to 6,433 Medicare beneficiaries, totaling 62,800 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Austin, TX
- Active Since 12/30/2005
- Last Updated 07/21/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164409108
Products in Payments
- ACTIVA (Device) $47,105
- INFINITY (Device) $4,950
- INVISX (Device) $3,968
- NUPLAZID (Drug) $1,753
- Infinity DBS Pulse Generators (Device) $875.48
- AUSTEDO (Drug) $866.34
- NORTHERA (Drug) $690.46
- RECLAIM (Device) $690.00
- INGREZZA (Drug) $541.09
- Dysport (Drug) $483.69
- GOCOVRI (Drug) $478.35
- Neupro (Drug) $446.76
- Xadago (Drug) $367.45
- INBRIJA (Drug) $367.18
- NOURIANZ (Drug) $344.67
- Austedo XR (Drug) $332.86
- APOKYN (Drug) $270.99
- NUEDEXTA (Drug) $255.16
- BOTOX (Biological) $246.75
- RYTARY (Drug) $238.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Austin
Dr. Elliot Frohman, Md Phd, MD PHD
Neurology — Payments: $633,909
Neurology $633,909
Dr. David Morledge, M.d, M.D
Neurology — Payments: $180,453
Neurology $180,453
Dr. Sami Aboumatar, M.d, M.D
Neurology — Payments: $159,184
Neurology $159,184
Dr. Subhashie Wijemanne, M.d, M.D
Neurology — Payments: $140,816
Neurology $140,816
Dr. Krishna Pokala, Md, MD
Neurology — Payments: $103,512
Neurology $103,512
Dr. Rajat Gupta, M.d, M.D
Neurology — Payments: $91,931
Neurology $91,931